UCB and Microsoft expand drug development partnership
UCB and Microsoft have entered into a new multi-year, strategic collaboration.
Belgium
Latest in
Belgium
Roche and UCB partner to develop antibody therapy for Alzheimer’s
Roche and its unit Genentech have agreed to a global, exclusive licence agreement with Belgian company UCB to develop and…
UCB acquires Engage Therapeutics for $125m
Belgian biopharmaceutical firm UCB has acquired US-based pharmaceutical company Engage Therapeutics for a cash consideration of $125m.
Orionis and Novartis enter drug discovery deal
Life sciences firm Orionis Biosciences has partnered with Novartis to discover and design new drugs for the treatment of a…
Galapagos expands fibrosis research collaboration with Fibrocor
Galapagos has expanded its research collaboration with Candian firm Fibrocor Therapeutics, which develops tissue-specific therapeutics for fibrotic diseases.
Promethera closes Series D funding round to support expansion
Cell-based drugs developer Promethera Biosciences has closed a Series D financing round to support its expansion in Asian markets, along…
Newpharma collaborates with Ingenico for e-payments
Belgian online pharmacy firm Newpharma has partnered with UK-based payments company Ingenico Group to enable secure payments for pharmaceutical buyers.
UCB acquires Ra Pharma for $2.1bn to enrich its rare disease portfolio
UCB has acquired Massachusetts-based Ra Pharmaceuticals for $48 per share, bringing the total transaction to a value of approximately $2.1bn.
By